Search
Lyra Therapeutics Inc
LYRAAdd to Watchlist
0.495USD
0.0000.00%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
1.01MMarket Cap
LossP/E TTM
Lyra Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-03-16The current valuation score of Lyra Therapeutics Inc is 5.98, ranking 341 out of 393 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.02, which is -94.86% below the recent high of -0.00 and -24905.61% above the recent low of -5.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
